T-group (topology)
7519.1.1 ATP synthase (F1-ATPase), gamma subunit
Ligands and drugs
1,135
Member domains
27
with ligand contacts (≤ 4 Å)
2.4% of members
30
with DrugDomain annotations
2.6% of members
28
with a DrugBank compound
2.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7519.1.1 belongs to X-group 7519 ATP synthase (F1-ATPase), gamma subunit, which has 5 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04005 | UTP | Uridine 5'-triphosphate | 13 |
| DB00171 | ATP | ATP | 3 |
| DB04216 | QUE | Quercetin | 3 |
| DB08399 | PIT | Piceatannol | 3 |
| DB02709 | STL | Resveratrol | 2 |
| DB07384 | — | — | 1 |
| DB07394 | — | AUROVERTIN B | 1 |
| DB08629 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UTP | URIDINE 5'-TRIPHOSPHATE | 13 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 3 |
| PIT | PICEATANNOL | 2 |
| QUE | 3,5,7,3',4'-PENTAHYDROXYFLAVONE | 2 |
| STL | RESVERATROL | 2 |
| ZH7 | (3~{E},5~{E},7~{E},9~{R},10~{R},11~{E},13~{E},17~{S},18~{S},20~{S})-18-methoxy-20-[(~{R})-[(2~{R},3~{R},4~{S},5~{R},6~{R})-6-[(2~{R})-3-methoxy-2-[(2~{R},4~{S},5~{S},6~{S})-5-[(2~{S},4~{R},5~{R},6~{R})-4-methoxy-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4,6-dimethyl-4-oxidanyl-oxan-2-yl]oxy-propyl]-3,5-dimethyl-2,4-bis(oxidanyl)oxan-2-yl]-oxidanyl-methyl]-10-[(2~{R},3~{S},4~{S},5~{R},6~{S})-5-methoxy-6-methyl-3,4-bis(oxidanyl)oxan-2-yl]oxy-3,5,7,9,13-pentamethyl-17-oxidanyl-1-oxacycloicosa-3,5,7,11,13-pentaen-2-one | 1 |
| ZHD | (3~{E},5~{Z},7~{E},9~{R},10~{S},11~{E},13~{E},15~{E},17~{R},18~{S},20~{S})-20-[(1~{R})-1-[(2~{S},3~{R},4~{R},5~{S},6~{R})-5-[(2~{S},4~{S},5~{S},6~{R})-5-[(2~{S},4~{R},5~{R},6~{R})-4,6-dimethyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-methyl-4-oxidanyl-oxan-2-yl]oxy-3-methoxy-6-(3-methoxypropyl)-5-methyl-2,4-bis(oxidanyl)oxan-2-yl]ethyl]-5,18-dimethoxy-3,7,9,11,13,15-hexamethyl-10-[(2~{R},3~{S},4~{R},5~{R},6~{S})-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-17-oxidanyl-1-oxacycloicosa-3,5,7,11,13,15-hexaen-2-one | 1 |